| ALL (n = 31) | BL (n = 21) | BCL-U (n = 10) |
Age at diagnosis Median (range) | 45 (19 - 74) | 50 (19 - 74) | 33 (27 - 65) |
c-Myc translocation (n) | 29 | 19 | 10 |
BCL-2 + (n) Bcl2 translocation (n) | 8 3 | 3 0 | 5 3 |
Ki67(%) Median (range) | 99 (40 - 100) | 100 (40 - 100) | 95 (90 - 100) |
LDH Median (range) | 519 (136 - 10940) | 473 (136 - 3934) | 520 (187 - 10940) |
Risk Level HR (n) LR (n) | 28 3 | 19 2 | 9 1 |
Clinical Stage 1 2 3 4 |
2 8 5 16 |
2 5 3 11 |
0 3 2 5 |
CNS + at baseline (n) | 3 | 3 | 0 |
CHOP/CHOP-R/other first (n) | 10 | 6 | 4 |
# CODOX-M (median, range) # IVAC (median, range) | 2 (1 - 3) 2 (0 - 2) | 2 (1 - 3) 2 (0 - 2) | 1 (1 - 2) 2 (0 - 2) |
Rituximab (n) # infusions (median, range) | 22 3 (0 - 7) | 14 2 (0 - 4) | 8 4 (0 - 7) |
Recommended Rx completed (n) | 22 | 14 | 8 |